Tace

• Tace is a targeted treatment for liver cancer, delivering chemotherapy directly to tumors.
• It works by blocking the tumor’s blood supply, starving it of nutrients and oxygen.
• The procedure is minimally invasive, performed by interventional radiologists.
• Common side effects include pain, nausea, and fever, usually manageable.
• Recovery typically involves a hospital stay of 1-2 days, with gradual return to normal activities.

What is Tace (Transarterial Chemoembolization)?

Transarterial Chemoembolization (TACE) is a procedure that combines chemotherapy with an embolic agent to treat liver tumors. This innovative approach is particularly effective for primary liver cancer (hepatocellular carcinoma) and metastatic cancers that have spread to the liver. The goal of TACE is to deliver a high concentration of chemotherapy drugs directly to the tumor, minimizing systemic exposure and its associated side effects, while simultaneously cutting off the tumor’s blood supply. This dual action aims to shrink the tumor or slow its growth, improving patient outcomes.

The procedure is performed by an interventional radiologist. According to the American Cancer Society, liver cancer is a significant global health concern, and targeted therapies like TACE play a crucial role in its management, especially for patients who are not candidates for surgery or transplantation.

Tace for Liver Cancer: How the Procedure Works

The Tace treatment for liver cancer involves a precise, multi-step process. First, a small incision is made, usually in the groin, to access the femoral artery. A thin, flexible catheter is then guided through the arterial system, using real-time imaging (fluoroscopy), until it reaches the hepatic artery, which supplies blood to the liver. The radiologist carefully navigates the catheter into the smaller arteries that directly feed the liver tumor.

Once the catheter is correctly positioned, a mixture of chemotherapy drugs and tiny embolic particles is injected. The chemotherapy drugs directly attack the cancer cells, while the embolic particles block the blood flow to the tumor. This blockage starves the tumor of oxygen and nutrients, intensifying the effect of the chemotherapy and preventing the drugs from being washed away too quickly. This localized delivery maximizes the drug’s impact on the tumor while sparing healthy liver tissue. The procedure typically lasts 1-3 hours, depending on the number and size of the tumors being treated.

Side Effects and Recovery After Tace

Patients undergoing Tace side effects and recovery can expect a range of experiences. Immediately after the procedure, it is common to experience post-embolization syndrome, which includes symptoms such as:

• Abdominal pain or discomfort
• Nausea and vomiting
• Fever and chills
• Fatigue

These symptoms are usually managed with medication and typically subside within a few days. Most patients remain in the hospital for 1-2 days for observation and pain management. Recovery at home involves resting and gradually returning to normal activities over one to two weeks. It is crucial for patients to follow their doctor’s post-procedure instructions, which may include avoiding strenuous activities and monitoring for any unusual symptoms.

Long-term side effects are less common but can include liver dysfunction or infection, though these are rare. Regular follow-up appointments, including imaging scans, are essential to monitor the tumor’s response to treatment and assess liver function. The overall goal of Tace is to improve quality of life and extend survival for patients with liver cancer, balancing treatment efficacy with manageable side effects.